相关实验视频

Updated: Jul 21, 2025

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

维生素D2代谢产物被人类CYP24A1无活化

Lei Li¹, Robert C Tuckey¹

¹School of Molecular Sciences, The University of Western Australia, Perth, WA 6009, Australia.

The Journal of steroid biochemistry and molecular biology

|July 26, 2023

概括

通过CYP24A1代谢维生素D2和D3,25-氧维生素D的失活率与25-氧维生素D的失活率相似,但1,25-二氧维生素D的失活率较慢2. 这表明维生素D2可能在体内增加了代谢稳定性.

科学领域:

生物化学生物化学
分子生物学分子生物学
内分泌学在内分泌学.

背景情况:

维生素D,形式为D2和D3,由线粒体酶CYP24A1调节.
通过CYP24A1氧化维生素D2的代谢途径尚未完全理解.
了解这些途径对于理解维生素D稳态至关重要.

研究的目的:

为了阐明25-氧维生素D2和1,25-二氧维生素D2由人类CYP24A1.1.的氧化途径.
为了比较维生素D2和维生素D3的新陈代谢动力学,secosteroids.
调查对维生素D有效性和稳定性的影响.

主要方法:

利用了人类CYP24A1酶的表达和纯化.
采用脂囊泡来模仿线粒体膜环境.
分析了氧化产物和确定了运动参数 (kcat/Km).

主要成果:

确定了同样的主要侧链氧化途径,用于25(OH) D2和1,25(OH) 2D2.
通过CYP27B1.1.通过D2和D3途径之间的代谢中间体的相互转换证明了.
在25(OH) D2和25(OH) D3基化中发现了类似的CYP24A1的催化效率 (kcat/Km).
观察到1,25(OH) 2D2的催化效率明显低于1,25(OH) 2D3.2的催化效率.

结论:

CYP24A1通过类似的途径代谢维生素D2和D3二类固醇.
维生素D2和维生素D3在低度下同样有效地维持血清25...OH) D水平.
1,25-二氧维生素D2在体内表现出比1,25-二氧维生素D3更大的代谢稳定性.

关键词:

1α,25-二氧维生素 D2 的含量.25 基维生素 D2 的含量在 CYP24A1 中.氧化液的氧化方式氧化过程中的氧化.维生素D2 维生素D2 是一种维生素.

更多相关视频

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

相关概念视频

Role of Skin in Vitamin D Synthesis

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...

Drug Metabolism: Phase II Reactions

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...

Drug Biotransformation: Overview

Drug Biotransformation: Overview

Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...

Drug Metabolism: Phase I Reactions

Drug Metabolism: Phase I Reactions

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...